
    
      The Study drug

        -  Vancomycin : a glycopeptide antibiotic, is the first line agent in the treatment of
           methicillin resistant staphylococcus aureus

      Study design : Randomized controlled trials

      Study Drug Administration

        -  If your doctor believes you are eligible, and you agree to take part in this study, you
           will be randomized to two treatment groups.
    
  